Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults
Clinical trial NCT01846104 · COMPLETED
Trial details
- NCT number
- NCT01846104
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-30
- Primary completion
- 2013-06-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.